Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2015 Publisher: Glaxo Wellcome UK Ltd, trading as GlaxoSmithKline UK, Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Ventolin Injection 500 micrograms (0.5mg) in 1ml.
Pharmaceutical Form |
---|
A colourless or faintly straw coloured solution for injection. |
Ventolin Injection 500 micrograms (0.5mg) in 1ml (500 micrograms/ml) is presented as ampoules of 1ml, each containing 500 micrograms salbutamol as salbutamol sulfate BP in a sterile isotonic solution.
Active Ingredient | Description | |
---|---|---|
Salbutamol |
Salbutamol is a selective β2-agonist providing short-acting (4-6 hour) bronchodilation with a fast onset (within 5 minutes) in reversible airways obstruction. At therapeutic doses it acts on the β2-adrenoceptors of bronchial muscle. Salbutamol is administered for the symptomatic relief of bronchospasm associated with chronic or acute asthma, bronchitis or other obstructive pulmonary diseases. |
List of Excipients |
---|
Sodium chloride |
Clear, neutral glass ampoules, packed in plastic trays with a cardboard sleeve over the trays.
Pack size: 1ml ampoules in plastic trays of 5.
Glaxo Wellcome UK Ltd, trading as GlaxoSmithKline UK, Stockley Park West, Uxbridge, Middlesex, UB11 1BT
PL 10949/0084
6 September 2000
Drug | Countries | |
---|---|---|
VENTOLIN | Australia, Canada, Cyprus, Estonia, Spain, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.